Research and development of ultra-sensitive PON detection of sars-COV-2 and influenza a antigens using graphene biosensors for AOI #11B: enabling technologies to support home-based diagnostics for…
Ended Definitive Contract Awarded Last action
- Contract number
- 75A50122C00039
- Awardee
-
Grip Molecular Technologies Inc. UEI NXXSC2FSQCS6
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $354,267
Award facts
- Opportunity
-
- EZBAA20100SOL0002 Solicitation number
- Contract value 100% obligated
- $354,267.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Basic Research
- Pricing
- Firm Fixed Price
- Place of performance
- St Paul, MN 55102, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$291,355 | |
| Change Order | $0 | |
| Original award | $645,622 |
About this award
This is a $354,267.22 firm fixed price definitive contract awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Grip Molecular Technologies Inc., a small disadvantaged business. The contract involves research and development of ultra-sensitive photonic integrated circuit detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Influenza A antigens using graphene biosensors. The goal is to support the development of home-based diagnostics for acute SARS-CoV-2 infection, as part of the agency's Enabling Technologies to Support Home-Based Diagnostics for SARS-CoV-2 Acute Infection program. The work will be performed in St. Paul, Minnesota over a one-year period from July 2022 to October 2023. Grip Molecular Technologies Inc. has also received sub-awards from the Atlanta Center for Microsystems Engineered Point-of-Care Technologies program for its expertise in at-home medical diagnostics using advanced biosensor technology.
Description
Research and development of ultra-sensitive PON detection of sars-COV-2 and influenza a antigens using graphene biosensors for AOI #11B: enabling technologies to support home-based diagnostics for sars-COV-2 acute infection
Quick answers
Who was awarded contract 75A50122C00039?
75A50122C00039 was awarded to Grip Molecular Technologies Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on July 28, 2022.
How much is contract 75A50122C00039 worth?
The government has obligated $354,267 on 75A50122C00039.
Was contract 75A50122C00039 competed?
The extent of competition for 75A50122C00039 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award